News Search

Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.

Physician-scientists at the Herbert Irving Comprehensive Cancer Center are pioneering new tools--3D organoids--for treating head and neck cancer.

Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.

In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.